Engaging with quality improvement in anticoagulation management.

about

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics

P2860

Q33910601-4375B194-F1A3-4B0A-BE2E-F2A5BE1CEEDF

P2860

Engaging with quality improvement in anticoagulation management.

Item

http://www.wikidata.org/entity/Q36771378

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Engaging with quality improvement in anticoagulation management.

@ast

Engaging with quality improvement in anticoagulation management.

@en

type

Item

label

Engaging with quality improvement in anticoagulation management.

@ast

Engaging with quality improvement in anticoagulation management.

@en

prefLabel

Engaging with quality improvement in anticoagulation management.

@ast

Engaging with quality improvement in anticoagulation management.

@en

P1476

Engaging with quality improvement in anticoagulation management.

@en

P2093

Eva Kline-Rogers

http://www.w3.org/2001/XMLSchema#string

Geoffrey D Barnes

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Adherence to guidelines for avoiding drug interactions associated with warfarin--a Nationwide Swedish Register Study

Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

P2888

s11239-015-1184-8

P304

403-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-015-1184-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273351993

http://www.w3.org/2001/XMLSchema#string

P698

25772116

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

4822820

http://www.w3.org/2001/XMLSchema#string

Engaging with quality improvement in anticoagulation management.

about

P2860

P2860

Engaging with quality improvement in anticoagulation management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932